Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 22, 2015 12:54 AM ET

Healthcare Equipment and Supplies

Company Overview of FzioMed, Inc.

Company Overview

FzioMed, Inc., a medical device company, develops, manufactures, and commercializes biomaterial technology for use in surgery and other medical applications. It offers adhesion barrier gels for spine surgery as an adjunct to posterior lumbar laminectomy, laminotomy, or discectomy procedures for reducing pain, radiculopathy, and lower extremity weakness; and the incidence, extent, and severity of postoperative adhesions. The company also provides adhesion barrier gels for tendon and peripheral nerve surgery to coat surgically traumatized tissues during tendon and/or peripheral nerve surgeries, such as in foot, knee, shoulder, and hand surgery. In addition, FzioMed, Inc. offers absorbable adhe...

231 Bonetti Drive

San Luis Obispo, CA 93401

United States

Founded in 1996

Phone:

805-546-0610

Fax:

805-546-0571

Key Executives for FzioMed, Inc.

Chief Executive Officer and President
Age: 62
Founder and Executive Chairman
Vice President of Clinical Affairs
Age: 69
Vice President of Research and Development
Vice President of Sales
Compensation as of Fiscal Year 2014.

FzioMed, Inc. Key Developments

FzioMed Receives Approval for Dynavisc(R) in Australia

FzioMed announced the inclusion of Dynavisc on the Australian Register of Therapeutic Goods (ARTG). Dynavisc is an absorbable, clear, viscoelastic gel that is applied to tendons and peripheral nerves to reduce fibrosis and the formation of adhesions following surgery. Dynavisc received a CE mark in January 2012 and is sold in the EU through independent distributors. Dynavisc, is a sister product to Oxiplex(R) and Medishield(TM) (distributed by Medtronic), which have been marketed for more than ten years in 70 countries to reduce the incidence of adhesions and for the reduction of pain after spine surgery. Oxiplex is not yet approved in the United States despite having demonstrated safety and effectiveness in clinical studies involving more than 500 patients. A Citizen Petition under 21 CFR 10.33 is still under review by FDA.

Similar Private Companies By Industry

Company Name Region
Medikmark, Inc. United States
Darma Inc. United States
Sonic Technology Products, Inc. United States
Data Sciences International, Inc. United States
Leto Solutions, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FzioMed, Inc., please visit www.fziomed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.